Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totalling 700 shares, a decrease of 46.2% from the June 30th total of 1,300 shares. Based on an average daily volume of 1,300 shares, the short-interest ratio is currently 0.5 days.

Revolution Medicines Stock Performance

RVMDW remained flat at $0.21 during trading on Friday. The company had a trading volume of 100 shares, compared to its average volume of 5,970. The company has a 50-day simple moving average of $0.15 and a 200-day simple moving average of $0.19. Revolution Medicines has a twelve month low of $0.03 and a twelve month high of $1.05.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.